Artificial Intelligence – Lovers, Haters, and Their Arguments – Asrar Qureshi’s Blog Post #968
![Image](https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgrdc5Gx7GpoCpOvBUmMcdrp7L8JyVoOTiEGpzFCPsL-rcGMI-71U7JTTy-p_HNgNZ3XW7dZLJFU7YGCEqj7Esg4GvYEnbflnBpS9OvaH2OqwiA7mvE8sK_cZNUDi_0fAJxzHO74_heexirF2XA6tNnEwkGhjLlcqIv2f6HKb7c5RWXF8X6-N9TxOcE6uk/w266-h400/ARon%20Lach.webp)
Generative AI – Lovers, Haters, and Their Arguments – Asrar Qureshi’s Blog Post #968 Dear Colleagues! This is Asrar Qureshi’s Blog Post 968 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to aq.pharmaveterans@gmail.com for publishing your contributions here. Credit: Ron Lach Credit: Cedric Fauntleroy Credit: iam hogir Credit: Mikhail Nilov Credit: Nabath Otieno Credit: ROMAN ODINTSOV Help for this two-part blogpost has been taken from ChatGPT4o, HubSpot, Mckinsey, and MIT. Prologue Generative AI has sparked significant debate, drawing strong opinions from both advocates and critics. The technology's potential to transform industries and society at large is undeniable, but so are the concerns it raises. CSER – Center for the Study of Existential Risk – is an interdisciplinary research center within the University of Cambridge, UK. Their website says, ‘We are dedicated to the study and mitigatio